Renal pelvis cancer
Renal pelvic cancer is a tumor that occurs in the epithelium of the renal pelvis or calyx, accounting for about 10% of all renal tumors. Interstitial nephritis, long-term use of painkillers, chronic inflammation or stone stimulation, and contact with carcinogens are often the causes of renal pelvic tumors. Most patients are over 40 years old, and there are more men than women, about 3:1. There is no significant difference in the incidence of left and right sides. Those who occur on both sides at the same time account for about 2-4%. Because the renal pelvis wall is thin and surrounded by abundant lymphatic tissue, the tumor is easy to metastasize to the para-aortic and cervical lymph nodes; the main organs for hematogenous metastasis are the lungs, liver and bones.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
Most of them are over 40 years old, and there are more males than females. -
Related symptoms:
Lower abdominal distension and pain ureteral obstruction urinary pain lump in waist swollen lymph nodes -
Concurrent disease:
Related Drugs
Medroxyprogesterone acetate dispersible tablets
Indication: Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.
Manufacturer:
Nanjing Cuccess Pharmaceutical Co., Ltd.
Mycophenolate mofetil tablets
Indication: It can be used to prevent rejection of allogeneic renal transplant patients and treat refractory rejection. It can also be used simultaneously with cyclosporine and corticosteroids.
Related Ingredients